SCI
VRTX icon

S&CO Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

S&CO Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Hold
4,103
– – 0.11% 116
2025
Q4 		$1.86M Hold
4,103
– – 0.12% 118
2025
Q3 		$1.61M Hold
4,103
– – 0.1% 122
2025
Q2 		$1.83M Hold
4,103
– – 0.12% 120
2025
Q1 		$1.99M Buy
+4,103
New +$1.91M 0.13% 113

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

S&CO Inc's VRTX Position: Q1 2026 in Review

S&CO Inc held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 4,103 shares worth $1.83M. The position accounts for 0.11% of the portfolio, ranked #116.

S&CO Inc first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.99M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • S&CO Inc held 4,103 shares of Vertex Pharmaceuticals worth $1.83M as of Q1 2026.
  • S&CO Inc left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.11% of S&CO Inc's portfolio in Q1 2026, its #116 holding.
  • S&CO Inc first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • S&CO Inc's Vertex Pharmaceuticals position peaked at $1.99M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.